Basics Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries. IPO Date: January 1, 1987 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $1.54B Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 2.46% Avg Daily Range (30 D): $0.63 | 2.63% Avg Daily Range (90 D): $0.42 | 2.25% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .84M Avg Daily Volume (90 D): .98M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 1,263 Avg Inst. Trade: $1.33M Avg Inst. Trade (30 D): $1.83M Avg Inst. Trade (90 D): $1.76M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.37M Avg Closing Trade (30 D): $2.39M Avg Closing Trade (90 D): $1.92M Avg Closing Volume: 81.16K     News Dec 4, 2025 @ 1:01 AM Axogen Announces FDA Approval of Biologics License... Source: Axogen, Inc. Oct 1, 2025 @ 2:50 PM AXGN Investors Have Opportunity to Join Axogen, In... Source: Business Wire Jul 30, 2025 @ 5:00 PM Global Amniotic Membrane Market Poised for Extraor... Source: Delveinsight Feb 11, 2025 @ 9:58 PM Axogen, Inc. to report 2024 fourth quarter and ful... Source: N/A Oct 7, 2024 @ 7:45 PM Bruker Stock Gains From Its Latest Acquisition of ... Source: Zacks Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.04 $.02 $.01 Diluted EPS $-.05 $.01 $.01 Revenue $ 214.71M $ 60.08M $ 56.66M Gross Profit $ 160.52M $ 45.99M $ 42.02M Net Income / Loss $ -2.1M $ .71M $ .58M Operating Income / Loss $ 3.94M $ 1.91M $ 1.67M Cost of Revenue $ 54.19M $ 14.09M $ 14.64M Net Cash Flow $ 3.24M $ 1.87M $ 1.94M PE Ratio